Cosan (CSAN3) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Net loss of R$320 million in 2Q26, a 66% improvement year-over-year, mainly due to lower tax expenses, improved financial results, and reduced G&A costs, despite a one-off impairment of R$233 million for Port São Luís.
Expanded net debt decreased 47% year-over-year to R$9.2 billion, reflecting liability management and proceeds from divestments and the Compass IPO.
Major capital structure simplification included Compass's secondary IPO (R$2.3 billion net proceeds), partial sale of Radar's portfolio (R$586 million attributable), and a letter of intent for the sale of Port São Luís.
Court approval of Raízen's restructuring plan and ongoing organizational restructuring, including the delisting process from NYSE.
Financial highlights
Net operating revenue grew 3% year-over-year to R$10.8 billion in 2Q26.
Gross profit increased 12% to R$4.0 billion, with a 31% sequential rise.
Adjusted EBITDA for the portfolio: Rumo R$2.3 billion (-1% YoY), Compass R$1.3 billion (+5%), Moove R$475 million (-6%), Radar -R$29 million.
Net loss improved to R$320 million from R$946 million in 2Q25; excluding one-off effects, recurring net loss would be R$167 million.
Effective income tax and social contribution expense decreased by R$228 million year-over-year.
Outlook and guidance
DSCR guidance introduced: expected to reach 0.8x–1.2x by year-end 2026, supported by ordinary dividends and reduced financial expenses.
Improvement in DSCR anticipated as benefits from debt prepayments and portfolio dividends materialize.
Latest events from Cosan
- Net loss narrowed to R$1.6 billion, with strong EBITDA and major deleveraging actions.CSAN3
Q1 2026 - EBITDA and net income fell, but major asset sales and capital raises improved leverage and liquidity.CSAN3
Q4 2025 - EBITDA and net income declined, but R$10.5 billion equity raised improved capital structure.CSAN3
Q3 2025 - EBITDA fell to R$6.0bn, net loss widened, and leverage rose to 3.4x as segment results diverged.CSAN3
Q2 2025 - EBITDA rose, net income fell, and management changes and acquisitions shaped the quarter.CSAN3
Q3 2024 - EBITDA rose 15% to R$7.1bn, net loss narrowed, and capital discipline remained strong.CSAN3
Q2 2024 - Net loss reached R$1.8B, EBITDA fell 30%, but net debt dropped to R$17.5B after asset sales.CSAN3
Q1 2025 - Net revenue rose 11%, but large impairments led to a R$9.4 billion net loss in 2024.CSAN3
Q4 2024